TY - JOUR
T1 - Acute kidney injury in pediatric hematopoietic cell transplantation
T2 - critical appraisal and consensus
AU - Raina, Rupesh
AU - Abu-Arja, Rolla
AU - Sethi, Sidharth
AU - Dua, Richa
AU - Chakraborty, Ronith
AU - Dibb, James T.
AU - Basu, Rajit K.
AU - Bissler, John
AU - Felix, Melvin Bonilla
AU - Brophy, Patrick
AU - Bunchman, Timothy
AU - Alhasan, Khalid
AU - Haffner, Dieter
AU - Kim, Yap Hui
AU - Licht, Christopher
AU - McCulloch, Mignon
AU - Menon, Shina
AU - Onder, Ali Mirza
AU - Khooblall, Prajit
AU - Khooblall, Amrit
AU - Polishchuk, Veronika
AU - Rangarajan, Hemalatha
AU - Sultana, Azmeri
AU - Kashtan, Clifford
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to International Pediatric Nephrology Association.
PY - 2022/6
Y1 - 2022/6
N2 - Hematopoietic cell transplantation (HCT) is a common therapy for the treatment of neoplastic and metabolic disorders, hematological diseases, and fatal immunological deficiencies. HCT can be subcategorized as autologous or allogeneic, with each modality being associated with their own benefits, risks, and post-transplant complications. One of the most common complications includes acute kidney injury (AKI). However, diagnosing HCT patients with AKI early on remains quite difficult. Therefore, this evidence-based guideline, compiled by the Pediatric Continuous Renal Replacement Therapy (PCRRT) working group, presents the various factors that contribute to AKI and recommendations regarding optimization of therapy with minimal complications in HCT patients.
AB - Hematopoietic cell transplantation (HCT) is a common therapy for the treatment of neoplastic and metabolic disorders, hematological diseases, and fatal immunological deficiencies. HCT can be subcategorized as autologous or allogeneic, with each modality being associated with their own benefits, risks, and post-transplant complications. One of the most common complications includes acute kidney injury (AKI). However, diagnosing HCT patients with AKI early on remains quite difficult. Therefore, this evidence-based guideline, compiled by the Pediatric Continuous Renal Replacement Therapy (PCRRT) working group, presents the various factors that contribute to AKI and recommendations regarding optimization of therapy with minimal complications in HCT patients.
KW - Acute kidney injury
KW - Bone marrow transplant
KW - Hematopoietic cell transplantation
KW - KRT
KW - Pediatrics
KW - Transplant
UR - http://www.scopus.com/inward/record.url?scp=85125932496&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125932496&partnerID=8YFLogxK
U2 - 10.1007/s00467-022-05448-x
DO - 10.1007/s00467-022-05448-x
M3 - Review article
C2 - 35224659
AN - SCOPUS:85125932496
SN - 0931-041X
VL - 37
SP - 1179
EP - 1203
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 6
ER -